HIPK1 Inhibition Protects against Pathological Cardiac Hypertrophy by Inhibiting the CREB‐C/EBP<i>β</i> Axis
Yihua Bei(Shanghai University), Junjie Xiao(Shanghai University)
Cited by 11
Related Papers
Circular RNAs: Promising Biomarkers for Human Diseases
|EBioMedicine|2018|823
miR-29b contributes to multiple types of muscle atrophy
|Nature Communications|2017|245
Cardiac Telocytes and Fibroblasts in Primary Culture: Different Morphologies and Immunophenotypes
|PLoS ONE|2015|106
Cathelicidin-related antimicrobial peptide protects against myocardial ischemia/reperfusion injury
|BMC Medicine|2019|76
Targeting miR-30d reverses pathological cardiac hypertrophy
|EBioMedicine|2022|60